The royalty aggregator’s proposed deals for HilleVax and Lava add to a pattern of “zombie” biotech buyouts this year as the ...

Detailed price information for KKR & Company LP (KKR-N) from The Globe and Mail including charting and trades.

Q2 2025 Earnings Call Transcript July 31, 2025 KKR & Co. Inc. beats earnings expectations. Reported EPS is $1.18, ...

Inside KKR's bold $1 trillion playbook: data centers, Harley deals, and the biggest credit fund in its history.

The positive earnings surprise came as the alternatives giant revealed new details about its partnership with Capital Group, ...

NEW YORK (Reuters) -Investment giant KKR reported a 9% rise in adjusted net income for the second quarter on Thursday, ...

The firm brought in $1.6 billion from outside investors for its fifth main growth fund and separately promoted dealmaker Sri Rao. The credit-card company reported increases in profit and sales in the ...

NEW YORK - Investeringsmaatschappij KKR & Co. Inc. (NYSE: KKR) heeft een meerderheidsbelang verworven in HealthCare Royalty Partners (HCRx), een bedrijf gespecialiseerd in biofarmaceutische ...

(Reuters) -Investment giant KKR said on Wednesday it had raised $6.5 billion to provide asset-backed financing, as companies ...

As part of the transaction, HCRx Chairman and CEO Clarke Futch will continue to lead the HCRx team and will maintain an ongoing substantial minority interest in HCRx.